Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Hepatitis C: move over interferon

Following approval of hepatitis C virus protease inhibitors Incivek and Victrelis, companies are partnering to devise all-oral combination antiviral regimens without interferon α. But the virus is a long way from vanquished. Ken Garber investigates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Hepatitis C life cycle.

References

  1. Kwong, A.D. et al. Nat. Biotechnol. 29, 993–1003. (2011).

    Article  CAS  Google Scholar 

  2. Lok, A. et al. J. Hepatol. 54, Suppl. 1, S536, abstract 1356 (2011).

    Article  Google Scholar 

  3. Fried, M. et al. AASLD annual meeting abstract LB-5 (2011).

  4. Garber, K. Nat. Biotechnol. 25, 1379–1381 (2007).

    Article  CAS  Google Scholar 

  5. Gao, M. et al. Nature 465, 96–100 (2010).

    Article  CAS  Google Scholar 

  6. Tellinghuisen, T.L. et al. Nature 435, 374–379 (2005).

    Article  CAS  Google Scholar 

  7. Chayama, K. et al. AASLD annual meeting abstract LB-4 (2011).

  8. Ge, D. et al. Nature 461, 399–401 (2009).

    Article  CAS  Google Scholar 

  9. Thomas, D.L. et al. Nature 461, 798–801 (2009).

    Article  CAS  Google Scholar 

  10. Murray, C.L. & Rice, C.M. Nature 465, 42–44 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garber, K. Hepatitis C: move over interferon. Nat Biotechnol 29, 963–966 (2011). https://doi.org/10.1038/nbt.2031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2031

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research